AccelerateBS India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 2, 2025, 8:50 pm

Market Cap	42.6 Cr.
Current Price	124
High / Low	250/105
Stock P/E	59.2
Book Value	11.8
Dividend Yield	0.65 %
ROCE	%
ROE	%
Face Value	10.0
PEG Ratio	0.15

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for AccelerateBS India Ltd

Competitors of AccelerateBS India Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
AccelerateBS India Ltd	42.6 Cr.	124	250/105	59.2	11.8	0.65 %	%	%	10.0
Industry Average	0 Cr	124.00		59.20	11.80	0.65%	0%	0%	10.00

All Competitor Stocks of AccelerateBS India Ltd

Quarterly Result

Metric	Mar 2023	Sep 2023	Mar 2024	Sep 2024
Sales	2.80	2.71	4.07	3.24
Expenses	2.09	2.16	2.72	3.02
Operating Profit	0.71	0.55	1.35	0.22
OPM %	25.36%	20.30%	33.17%	6.79%
Other Income	0.04	-0.89	0.01	0.02
Interest	0.04	0.01	0.01	0.00
Depreciation	0.06	0.07	0.07	0.06
Profit before tax	0.65	-0.42	1.28	0.18
Tax %	10.77%	30.95%	53.12%	27.78%
Net Profit	0.58	-0.56	0.59	0.13
EPS in Rs	1.87	-1.65	1.74	0.38

Last Updated: March 4, 2025, 1:23 am

Below is a detailed analysis of the quarterly data for AccelerateBS India Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Sales, as of Sep 2024, the value is ₹3.24 Cr.. The value appears to be declining and may need further review. It has decreased from 4.07 Cr. (Mar 2024) to ₹3.24 Cr., marking a decrease of 0.83 Cr..
For Expenses, as of Sep 2024, the value is ₹3.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.72 Cr. (Mar 2024) to ₹3.02 Cr., marking an increase of 0.30 Cr..
For Operating Profit, as of Sep 2024, the value is ₹0.22 Cr.. The value appears to be declining and may need further review. It has decreased from 1.35 Cr. (Mar 2024) to ₹0.22 Cr., marking a decrease of 1.13 Cr..
For OPM %, as of Sep 2024, the value is 6.79%. The value appears to be declining and may need further review. It has decreased from 33.17% (Mar 2024) to 6.79%, marking a decrease of 26.38%.
For Other Income, as of Sep 2024, the value is ₹0.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Mar 2024) to ₹0.02 Cr., marking an increase of 0.01 Cr..
For Interest, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.01 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 0.01 Cr..
For Depreciation, as of Sep 2024, the value is ₹0.06 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.07 Cr. (Mar 2024) to ₹0.06 Cr., marking a decrease of 0.01 Cr..
For Profit before tax, as of Sep 2024, the value is ₹0.18 Cr.. The value appears to be declining and may need further review. It has decreased from 1.28 Cr. (Mar 2024) to ₹0.18 Cr., marking a decrease of 1.10 Cr..
For Tax %, as of Sep 2024, the value is 27.78%. The value appears to be improving (decreasing) as expected. It has decreased from 53.12% (Mar 2024) to 27.78%, marking a decrease of 25.34%.
For Net Profit, as of Sep 2024, the value is ₹0.13 Cr.. The value appears to be declining and may need further review. It has decreased from 0.59 Cr. (Mar 2024) to ₹0.13 Cr., marking a decrease of 0.46 Cr..
For EPS in Rs, as of Sep 2024, the value is 0.38. The value appears to be declining and may need further review. It has decreased from 1.74 (Mar 2024) to 0.38, marking a decrease of 1.36.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 2:16 pm

Metric	Mar 2024	TTM
Sales	6.78	7.31
Expenses	4.87	5.74
Operating Profit	1.91	1.57
OPM %	28.17%	21.48%
Other Income	-0.89	0.03
Interest	0.02	0.01
Depreciation	0.15	0.13
Profit before tax	0.85	1.46
Tax %	97.65%
Net Profit	0.03	0.72
EPS in Rs	0.09	2.12
Dividend Payout %	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)

No data available for trend analysis.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	33%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-10%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	-40%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Last Updated: Unknown

Balance Sheet

Last Updated: March 14, 2025, 2:28 pm

Month	Mar 2024	Sep 2024
Equity Capital	2.15	3.44
Reserves	1.76	0.60
Borrowings	0.54	0.02
Other Liabilities	0.40	0.66
Total Liabilities	4.85	4.72
Fixed Assets	0.40	0.40
CWIP	-0.00	-0.00
Investments	-0.00	-0.00
Other Assets	4.45	4.32
Total Assets	4.85	4.72

Below is a detailed analysis of the balance sheet data for AccelerateBS India Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹3.44 Cr.. The value appears strong and on an upward trend. It has increased from 2.15 Cr. (Mar 2024) to ₹3.44 Cr., marking an increase of 1.29 Cr..
For Reserves, as of Sep 2024, the value is ₹0.60 Cr.. The value appears to be declining and may need further review. It has decreased from 1.76 Cr. (Mar 2024) to ₹0.60 Cr., marking a decrease of 1.16 Cr..
For Borrowings, as of Sep 2024, the value is ₹0.02 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.54 Cr. (Mar 2024) to ₹0.02 Cr., marking a decrease of 0.52 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹0.66 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.40 Cr. (Mar 2024) to ₹0.66 Cr., marking an increase of 0.26 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹4.72 Cr.. The value appears to be improving (decreasing). It has decreased from 4.85 Cr. (Mar 2024) to ₹4.72 Cr., marking a decrease of 0.13 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹0.40 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.40 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹4.32 Cr.. The value appears to be declining and may need further review. It has decreased from 4.45 Cr. (Mar 2024) to ₹4.32 Cr., marking a decrease of 0.13 Cr..
For Total Assets, as of Sep 2024, the value is ₹4.72 Cr.. The value appears to be declining and may need further review. It has decreased from 4.85 Cr. (Mar 2024) to ₹4.72 Cr., marking a decrease of 0.13 Cr..

Notably, the Reserves (₹0.60 Cr.) exceed the Borrowings (0.02 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2024
Cash from Operating Activity +	-1.13
Cash from Investing Activity +	0.57
Cash from Financing Activity +	1.96
Net Cash Flow	1.39

Free Cash Flow

Month	Mar 2024
Free Cash Flow	1.37

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Jan 2023	Mar 2023	Mar 2024
Debtor Days	126.96	110.80	103.90
Inventory Days
Days Payable
Cash Conversion Cycle	126.96	110.80	103.90
Working Capital Days	104.29	67.79	108.21
ROCE %			51.15%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2023	Mar 2024	Sep 2024
Promoters	70.59%	70.72%	70.76%
Public	29.41%	29.29%	29.25%
No. of Shareholders	197	247	346

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	0.15	1.97	2.57	4.22	6.78
Diluted EPS (Rs.)	0.15	1.97	2.57	4.22	6.78
Cash EPS (Rs.)	0.81	2.25	2.96	4.87	13.98
Book Value[Excl.RevalReserv]/Share (Rs.)	18.18	11.11	10.00	10.00	10.00
Book Value[Incl.RevalReserv]/Share (Rs.)	18.18	11.11	10.00	10.00	10.00
Revenue From Operations / Share (Rs.)	31.59	14.26	31.72	43.92	91.36
PBDIT / Share (Rs.)	8.94	3.81	4.29	6.79	20.68
PBIT / Share (Rs.)	8.26	3.53	3.66	6.08	19.59
PBT / Share (Rs.)	3.97	3.30	3.42	6.04	18.60
Net Profit / Share (Rs.)	0.14	1.97	2.33	4.15	12.88
PBDIT Margin (%)	28.28	26.73	13.51	15.47	22.63
PBIT Margin (%)	26.14	24.74	11.54	13.83	21.43
PBT Margin (%)	12.56	23.11	10.78	13.75	20.35
Net Profit Margin (%)	0.44	13.79	7.35	9.45	14.10
Return on Networth / Equity (%)	0.78	17.70	23.33	41.50	128.84
Return on Capital Employeed (%)	37.65	27.91	29.61	60.62	195.15
Return On Assets (%)	0.62	13.23	12.91	23.50	54.63
Long Term Debt / Equity (X)	0.13	0.11	0.23	0.00	0.00
Total Debt / Equity (X)	0.13	0.11	0.40	0.23	0.00
Asset Turnover Ratio (%)	1.75	1.14	1.85	2.94	0.00
Current Ratio (X)	31.14	4.13	2.63	1.81	1.14
Quick Ratio (X)	31.14	4.13	2.63	1.81	1.14
Interest Coverage Ratio (X)	202.15	16.40	17.82	193.42	20.93
Interest Coverage Ratio (Post Tax) (X)	100.28	9.46	10.70	119.14	14.04
Enterprise Value (Cr.)	65.99	0.00	0.00	0.00	0.00
EV / Net Operating Revenue (X)	9.72	0.00	0.00	0.00	0.00
EV / EBITDA (X)	34.36	0.00	0.00	0.00	0.00
MarketCap / Net Operating Revenue (X)	9.97	0.00	0.00	0.00	0.00
Price / BV (X)	17.32	0.00	0.00	0.00	0.00
Price / Net Operating Revenue (X)	9.97	0.00	0.00	0.00	0.00

After reviewing the key financial ratios for AccelerateBS India Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 0.15. This value is below the healthy minimum of 5. It has decreased from 1.97 (Mar 23) to 0.15, marking a decrease of 1.82.
For Diluted EPS (Rs.), as of Mar 24, the value is 0.15. This value is below the healthy minimum of 5. It has decreased from 1.97 (Mar 23) to 0.15, marking a decrease of 1.82.
For Cash EPS (Rs.), as of Mar 24, the value is 0.81. This value is below the healthy minimum of 3. It has decreased from 2.25 (Mar 23) to 0.81, marking a decrease of 1.44.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 18.18. It has increased from 11.11 (Mar 23) to 18.18, marking an increase of 7.07.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 18.18. It has increased from 11.11 (Mar 23) to 18.18, marking an increase of 7.07.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 31.59. It has increased from 14.26 (Mar 23) to 31.59, marking an increase of 17.33.
For PBDIT / Share (Rs.), as of Mar 24, the value is 8.94. This value is within the healthy range. It has increased from 3.81 (Mar 23) to 8.94, marking an increase of 5.13.
For PBIT / Share (Rs.), as of Mar 24, the value is 8.26. This value is within the healthy range. It has increased from 3.53 (Mar 23) to 8.26, marking an increase of 4.73.
For PBT / Share (Rs.), as of Mar 24, the value is 3.97. This value is within the healthy range. It has increased from 3.30 (Mar 23) to 3.97, marking an increase of 0.67.
For Net Profit / Share (Rs.), as of Mar 24, the value is 0.14. This value is below the healthy minimum of 2. It has decreased from 1.97 (Mar 23) to 0.14, marking a decrease of 1.83.
For PBDIT Margin (%), as of Mar 24, the value is 28.28. This value is within the healthy range. It has increased from 26.73 (Mar 23) to 28.28, marking an increase of 1.55.
For PBIT Margin (%), as of Mar 24, the value is 26.14. This value exceeds the healthy maximum of 20. It has increased from 24.74 (Mar 23) to 26.14, marking an increase of 1.40.
For PBT Margin (%), as of Mar 24, the value is 12.56. This value is within the healthy range. It has decreased from 23.11 (Mar 23) to 12.56, marking a decrease of 10.55.
For Net Profit Margin (%), as of Mar 24, the value is 0.44. This value is below the healthy minimum of 5. It has decreased from 13.79 (Mar 23) to 0.44, marking a decrease of 13.35.
For Return on Networth / Equity (%), as of Mar 24, the value is 0.78. This value is below the healthy minimum of 15. It has decreased from 17.70 (Mar 23) to 0.78, marking a decrease of 16.92.
For Return on Capital Employeed (%), as of Mar 24, the value is 37.65. This value is within the healthy range. It has increased from 27.91 (Mar 23) to 37.65, marking an increase of 9.74.
For Return On Assets (%), as of Mar 24, the value is 0.62. This value is below the healthy minimum of 5. It has decreased from 13.23 (Mar 23) to 0.62, marking a decrease of 12.61.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.13. This value is below the healthy minimum of 0.2. It has increased from 0.11 (Mar 23) to 0.13, marking an increase of 0.02.
For Total Debt / Equity (X), as of Mar 24, the value is 0.13. This value is within the healthy range. It has increased from 0.11 (Mar 23) to 0.13, marking an increase of 0.02.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.75. It has increased from 1.14 (Mar 23) to 1.75, marking an increase of 0.61.
For Current Ratio (X), as of Mar 24, the value is 31.14. This value exceeds the healthy maximum of 3. It has increased from 4.13 (Mar 23) to 31.14, marking an increase of 27.01.
For Quick Ratio (X), as of Mar 24, the value is 31.14. This value exceeds the healthy maximum of 2. It has increased from 4.13 (Mar 23) to 31.14, marking an increase of 27.01.
For Interest Coverage Ratio (X), as of Mar 24, the value is 202.15. This value is within the healthy range. It has increased from 16.40 (Mar 23) to 202.15, marking an increase of 185.75.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 100.28. This value is within the healthy range. It has increased from 9.46 (Mar 23) to 100.28, marking an increase of 90.82.
For Enterprise Value (Cr.), as of Mar 24, the value is 65.99. It has increased from 0.00 (Mar 23) to 65.99, marking an increase of 65.99.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 9.72. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 9.72, marking an increase of 9.72.
For EV / EBITDA (X), as of Mar 24, the value is 34.36. This value exceeds the healthy maximum of 15. It has increased from 0.00 (Mar 23) to 34.36, marking an increase of 34.36.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 9.97. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 9.97, marking an increase of 9.97.
For Price / BV (X), as of Mar 24, the value is 17.32. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 17.32, marking an increase of 17.32.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 9.97. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 9.97, marking an increase of 9.97.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of AccelerateBS India Ltd as of April 3, 2025 is: 84.37

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 3, 2025, AccelerateBS India Ltd is Overvalued by 31.96% compared to the current share price 124.00

Default values used*: Default value of 15% for ROE is used

Intrinsic Value of AccelerateBS India Ltd as of April 3, 2025 is: 409.48

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 3, 2025, AccelerateBS India Ltd is Undervalued by 230.23% compared to the current share price 124.00

Default values used*: Default value of 15% for ROE is used

Last 5 Year EPS CAGR: 385.34%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 17.05%, which is a positive sign. The company has higher reserves (1.18 cr) compared to borrowings (0.28 cr), indicating strong financial stability. The company has shown consistent growth in sales (7.05 cr) and profit (1.16 cr) over the years.	The stock has a high average Working Capital Days of 93.43, which may not be favorable. The stock has a high average Cash Conversion Cycle of 113.89, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AccelerateBS India Ltd:
1. Net Profit Margin: 0.44%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 37.65% (Industry Average ROCE: 0%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 0.78% (Industry Average ROE: 0%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 100.28
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 31.14
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 59.2 (Industry average Stock P/E: 59.2)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.13
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

AccelerateBS India Ltd. is a Public Limited Listed company incorporated on 09/09/2022 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L72200MH2022PLC390266 and registration number is 390266. Currently company belongs to the Industry of IT Consulting & Software. Company's Total Operating Revenue is Rs. 6.79 Cr. and Equity Capital is Rs. 2.15 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
IT Consulting & Software	Office 604, Quantum Tower, Off S.V. Road, Ram Baug, Mumbai Maharashtra 400064	investors@acceleratebs.com http://www.acceleratebs.com

Management
Name	Position Held
Mr. Kunal Arvind Shah	Chairman & Managing Director
Mr. Keyur Dipakkumar Shah	Whole Time Director
Ms. Ishani Kunal Shah	Executive Director
Ms. Ami Keyur Shah	Director & CFO
Mr. Krunal Bhupendra Katwala	Ind. Non-Executive Director
Mr. Pratik Pravin Doshi	Ind. Non-Executive Director
Mr. Hardik Naresh Bagadia	Ind. Non-Executive Director

FAQ

What is the intrinsic value of AccelerateBS India Ltd?

AccelerateBS India Ltd's intrinsic value (as of 02 April 2025) is ₹84.37 — 31.96% lower the current market price of ₹124.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 42.6 Cr. market cap, FY2025-2026 high/low of ₹250/105, reserves of 0.60 Cr, and liabilities of 4.72 Cr.

What is the Market Cap of AccelerateBS India Ltd?

The Market Cap of AccelerateBS India Ltd is 42.6 Cr..

What is the current Stock Price of AccelerateBS India Ltd as on 02 April 2025?

The current stock price of AccelerateBS India Ltd as on 02 April 2025 is 124.

What is the High / Low of AccelerateBS India Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of AccelerateBS India Ltd stocks is ₹250/105.

What is the Stock P/E of AccelerateBS India Ltd?

The Stock P/E of AccelerateBS India Ltd is 59.2.

What is the Book Value of AccelerateBS India Ltd?

The Book Value of AccelerateBS India Ltd is 11.8.

What is the Dividend Yield of AccelerateBS India Ltd?

The Dividend Yield of AccelerateBS India Ltd is 0.65 %.

What is the ROCE of AccelerateBS India Ltd?

The ROCE of AccelerateBS India Ltd is %.

What is the ROE of AccelerateBS India Ltd?

The ROE of AccelerateBS India Ltd is %.

What is the Face Value of AccelerateBS India Ltd?

The Face Value of AccelerateBS India Ltd is 10.0.